International Clinical Trial: A Phase II, Plateform Study, Open-label, Evaluating the Efficacy and Safety of Neoadjuvant Treatment in Patients With Surgically Resecable Pancreatic Adenocarcinoma

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808567) titled 'A Phase II, Plateform Study, Open-label, Evaluating the Efficacy and Safety of Neoadjuvant Treatment in Patients With Surgically Resecable Pancreatic Adenocarcinoma' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Condition: Pancreatic Adenocarcinoma Resectable Non Metastatic ECOG Performance Status Score of 0 or 1

Intervention: Drug: GnP

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: Janua...